Cassava Sciences | PTIE - Ebitda





Ebitda Changement Date
Abbott USD 2.43B 844M 2026-03
Amgen USD 3.86B 1.28B 2026-03
Biogen USD 450.8M 198.9M 2026-06
Cara Therapeutics USD -2.39M 3.16M 2025-03
Cassava Sciences USD -11.73M 33.44M 2025-09
Eisai JPY 34.15B 34.48B 2026-06
Eli Lilly USD 9.46B 3.54B 2026-09
Geron USD 3.83M 25.12M 2026-03
J&J USD 8.99B 721M 2026-06
Merck USD 1.42B 2.97B 2026-06
Novartis USD 8.62B 2.14B 2026-09
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.01B 18M 2026-06
Roche Holding CHF 13.43B 744M 2026-06